SHANLER STUART D.,쉔러, 스튜어트, 디.,POWALA CHRISTOPHER,포왈라, 크리스토퍼
申请号：
KR1020137024232
公开号：
KR1020140020912A
申请日:
2012.02.14
申请国别(地区):
KR
年份:
2014
代理人:
摘要：
The present invention provides a pharmaceutical composition for use in the treatment of erythema or telangiectasia associated with rosacea by topical administration of the composition, wherein the composition is a cream comprising oxymetazoline or a pharmaceutically acceptable salt thereof and 1% to 50% by weight of an emollient, said emollient comprising medium chain triglycerides diisopropyl adipate, oleyl alcohol, and lanolin. Also provided is a pharmaceutical composition for use in the treatment of erythema or telangiectasia associated with rosacea by topical administration of the composition, wherein the composition is a cream comprising oxymetazoline or a pharmaceutically acceptable salt thereof, and wherein the therapeutic effect of the composition is maintained for at least 27 days after final administration.본 발명은 다음에 관계한다: 치료요법적으로 유효량의 옥시메타졸린과 약학적으로 수용가능한 부형제를 포함하는 약학 조성물을 국소적으로 투여하는 것을 포함하는 a) 모세관확장증을 치료하는 방법은； b) 염증성 병소들의 치료 방법； 그리고 c) 홍반, 모세관확장증, 또는 염증성 병소들로부터 선택된 주사비의 두 가지 또는 그 이상의 증상을 치료하는 방법.
